Company: MDCXW
Filing Date: 2025-05-05
Form Type: 424B3
Source: 0001062993-25-008444
Chunk: 1

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-05
Form: 424B3
Chunk 1
---
 Commission, any state securities commission or the securities commission of any Canadian province or territory has approved or disapproved of the securities offered by this prospectus supplement or the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus supplement is May 5, 2025.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(Amendment No. 1)</div>

(Mark One)

☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

<div align='center'>For the fiscal year ended

OR</div>

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

<div align='center'>For the transition period from ___ to _____
Commission File Number

MEDICUS PHARMA LTD.
(Exact name of Registrant as specified in its Charter)</div>

| Ontario, Canada                 
 (State or other jurisdiction of 
 incorporation or organization)  | 98-1778211          
 (I.R.S. Employer    
 Identification No.) |

<div align='center'>300 Conshohocken State Rd., Suite 200
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code:(610) 636-0184
Securities registered pursuant to Section 12(b) of the Act:</div>

| Title of each class                                                                     | Trading Symbol(s) | Name of each exchange on which registered |
| Common shares, no par value                                                             | MDCX              | The Nasdaq Capital Market                 |
| Warrants, each exercisable for one common share at an exercise price of $4.64 per share | MDCXW             | The Nasdaq Capital Market                 |

<div align='center'>Securities registered pursuant to Section 12(g) of the Act:</div>

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes ☐ No ☒

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.
Yes ☐ No ☒

Indicate by check mark whether the registr